The "Virtual Clinical Trials Market Research Report by Study Design (Expanded Access Trials, Interventional Trials, and Observational Trials), by Implication (Cardiovascular Disease and Oncology) - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Virtual Clinical Trials Market is expected to grow from USD 2,092.67 Million in 2020 to USD 5,521.67 Million by the end of 2025.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward.
The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Virtual Clinical Trials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.
During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Research Execution
2.3. Research Outcome
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Study Design Outlook
3.4. Implication Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of telehealth
5.1.1.2. Growing adoption of digitization in healthcare sector globally
5.1.1.3. Proliferation in research and development activities coupled with favorable government support
5.1.2. Restraints
5.1.2.1. Concerns over large data collection, data accuracy and reliability, and technological failure
5.1.3. Opportunities
5.1.3.1. Ongoing technological advancements in healthcare industry
5.1.3.2. Emerging collaborations between biotechnology and clinical research companies
5.1.4. Challenges
5.1.4.1. Cumbersome and difficult process with enrolment and engagement activities
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Global Virtual Clinical Trials Market, By Study Design
6.1. Introduction
6.2. Expanded Access Trials
6.3. Interventional Trials
6.4. Observational Trials
7. Global Virtual Clinical Trials Market, By Implication
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Oncology
8. Americas Virtual Clinical Trials Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Virtual Clinical Trials Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. Europe, Middle East & Africa Virtual Clinical Trials Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AiCure LLC
12.2. Clinical Ink By GI Partners
12.3. CliniOps, Inc
12.4. Covance Inc
12.5. CRF Health By Genstar Capital
12.6. ERT
12.7. Everest Global, Inc
12.8. ICON PLC
12.9. IQVIA
12.10. LEO Innovation Lab
12.11. Medable, Inc.
12.12. Medidata Solutions
12.13. Medpace
12.14. Navitas Life Sciences, Inc.
12.15. Neoteryx, LLC
12.16. Oracle Corporation
12.17. Parexel International
12.18. Pfizer Inc.
12.19. Science 37
12.20. Tenthpin Management Consultants AG
12.21. VirTrial, LLC
For more information about this report visit https://www.researchandmarkets.com/r/eibu93
View source version on businesswire.com: https://www.businesswire.com/news/home/20210325005692/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
